Sangrix Inc.SGRX
Price (close)
$1.56
Market cap
—
P/E
—
Revenue (FY)
—
Net income
-$14.3M
Dividend yield
—
1-year total return
-98.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What Sangrix Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $80.5M | $6.3M | $6.3M | $2.9M | $39,495 | — |
| Net income | -$45.6M | $3.2M | -$28.2M | -$17.5M | -$4.4M | -$14.3M |
| Free cash flow | — | -$22.5M | -$6.9M | — | — | — |
More on SGRX.
- Sangrix Inc. summary
- Sangrix Inc. financial statements
- Sangrix Inc. key metrics
- Sangrix Inc. health scores and style box
- Sangrix Inc. earnings
- Sangrix Inc. dividends
- Sangrix Inc. valuation
- Sangrix Inc. ownership and insiders
- Sangrix Inc. peers
Figures from Sangrix Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.